ASX - By Stock
|
CSL |
Re:
Only a bit over 4 weeks until results announcement
|
|
PZ99
|
4 |
3.4K |
0 |
12/07/24 |
12/07/24 |
ASX - By Stock
|
4
|
3.4K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
New Player
|
|
PZ99
|
81 |
22K |
1 |
05/07/24 |
05/07/24 |
ASX - By Stock
|
81
|
22K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
How would involvement from a Venture capitalists or Private equity group look for Paradigm
|
|
PZ99
|
59 |
19K |
1 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
59
|
19K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
How would involvement from a Venture capitalists or Private equity group look for Paradigm
|
|
PZ99
|
59 |
19K |
8 |
29/02/24 |
29/02/24 |
ASX - By Stock
|
59
|
19K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
How would involvement from a Venture capitalists or Private equity group look for Paradigm
|
|
PZ99
|
59 |
19K |
10 |
27/02/24 |
27/02/24 |
ASX - By Stock
|
59
|
19K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
PZ99
|
327 |
111K |
1 |
19/02/24 |
19/02/24 |
ASX - By Stock
|
327
|
111K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
PZ99
|
327 |
111K |
0 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
327
|
111K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Appoints Business Development Consultant
|
|
PZ99
|
327 |
111K |
6 |
16/02/24 |
16/02/24 |
ASX - By Stock
|
327
|
111K
|
6
|
|
ASX - By Stock
|
NAB |
Re:
NAB money laundering and counter-terrorist financing laws
|
|
PZ99
|
186 |
72K |
3 |
13/02/24 |
13/02/24 |
ASX - By Stock
|
186
|
72K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
PZ99
|
236 |
83K |
6 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
236
|
83K
|
6
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
PZ99
|
236 |
83K |
8 |
05/02/24 |
05/02/24 |
ASX - By Stock
|
236
|
83K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Quarterly Activities/Appendix 4C Cash Flow Report
|
|
PZ99
|
236 |
83K |
1 |
01/02/24 |
01/02/24 |
ASX - By Stock
|
236
|
83K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: PAR Selected for Major OA Conference Presentations
|
|
PZ99
|
35 |
12K |
44 |
30/01/24 |
30/01/24 |
ASX - By Stock
|
35
|
12K
|
44
|
|
ASX - By Stock
|
CSL |
Grifols
|
|
PZ99
|
2 |
1.2K |
11 |
10/01/24 |
10/01/24 |
ASX - By Stock
|
2
|
1.2K
|
11
|
|
ASX - By Stock
|
PAR |
Re:
The Miracle of iPPS on MPS -Revisited
|
|
PZ99
|
75 |
26K |
3 |
15/11/23 |
15/11/23 |
ASX - By Stock
|
75
|
26K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Increases Cartilage Thickness in Phase 2 Trial
|
|
PZ99
|
218 |
77K |
6 |
18/10/23 |
18/10/23 |
ASX - By Stock
|
218
|
77K
|
6
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Update - Dividend/Distribution - CSL
|
|
PZ99
|
4 |
3.2K |
0 |
21/09/23 |
21/09/23 |
ASX - By Stock
|
4
|
3.2K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
Ann: Update - Dividend/Distribution - CSL
|
|
PZ99
|
4 |
3.2K |
5 |
13/09/23 |
13/09/23 |
ASX - By Stock
|
4
|
3.2K
|
5
|
|
ASX - By Stock
|
PAR |
Re:
Ann: 2023 Annual Report and Appendix 4E
|
|
PZ99
|
25 |
12K |
12 |
25/08/23 |
25/08/23 |
ASX - By Stock
|
25
|
12K
|
12
|
|
ASX - By Stock
|
PAR |
Re:
Ann: iPPS Demonstrates Multiple DMOAD Signals in Phase 2 Study
|
|
PZ99
|
386 |
169K |
2 |
11/04/23 |
11/04/23 |
ASX - By Stock
|
386
|
169K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Perspective
|
|
PZ99
|
9 |
3.5K |
4 |
28/03/23 |
28/03/23 |
ASX - By Stock
|
9
|
3.5K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
Ann: NWR Virtual Healthcare Conference Presentation
|
|
PZ99
|
88 |
30K |
1 |
24/03/23 |
24/03/23 |
ASX - By Stock
|
88
|
30K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Chief Financial Officer
|
|
PZ99
|
45 |
17K |
3 |
03/03/23 |
03/03/23 |
ASX - By Stock
|
45
|
17K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
News: CSL UPDATE 1-CSL's half-year profit beats estimates on robust blood plasma collections
|
|
PZ99
|
44 |
17K |
4 |
17/02/23 |
17/02/23 |
ASX - By Stock
|
44
|
17K
|
4
|
|
ASX - By Stock
|
CSL |
Re:
Fair Value
|
|
PZ99
|
117 |
57K |
10 |
03/02/23 |
03/02/23 |
ASX - By Stock
|
117
|
57K
|
10
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Change of Director's Interest Notice - Rennie
|
|
PZ99
|
21 |
10K |
14 |
22/12/22 |
22/12/22 |
ASX - By Stock
|
21
|
10K
|
14
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
PZ99
|
141 |
58K |
3 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
141
|
58K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
PZ99
|
141 |
58K |
0 |
09/12/22 |
09/12/22 |
ASX - By Stock
|
141
|
58K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
PZ99
|
141 |
58K |
0 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
58K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
PZ99
|
141 |
58K |
3 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
58K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm AGM Presentation
|
|
PZ99
|
141 |
58K |
1 |
01/12/22 |
01/12/22 |
ASX - By Stock
|
141
|
58K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
PZ99
|
670 |
266K |
2 |
26/11/22 |
26/11/22 |
ASX - By Stock
|
670
|
266K
|
2
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
PZ99
|
213 |
78K |
8 |
24/11/22 |
24/11/22 |
ASX - By Stock
|
213
|
78K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Paradigm CEO steps down & Appointment of MD
|
|
PZ99
|
213 |
78K |
4 |
23/11/22 |
23/11/22 |
ASX - By Stock
|
213
|
78K
|
4
|
|
ASX - By Stock
|
CSL |
Re:
Csl usd otc listing had a good night
|
|
PZ99
|
3 |
1.5K |
1 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
3
|
1.5K
|
1
|
|
ASX - By Stock
|
CSL |
Re:
Csl usd otc listing had a good night
|
|
PZ99
|
3 |
1.5K |
0 |
11/11/22 |
11/11/22 |
ASX - By Stock
|
3
|
1.5K
|
0
|
|
ASX - By Stock
|
PAR Biotech |
Re:
PAR Tweets
|
|
PZ99
|
23 |
9.7K |
0 |
08/11/22 |
08/11/22 |
ASX - By Stock
|
23
|
9.7K
|
0
|
|
ASX - By Stock
|
CSL |
Re:
News: CSL Australia's CSL raises annual profit forecast on Swiss acquisition
|
|
PZ99
|
6 |
3.0K |
1 |
18/10/22 |
18/10/22 |
ASX - By Stock
|
6
|
3.0K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
PZ99
|
670 |
266K |
8 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
670
|
266K
|
8
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
PZ99
|
670 |
266K |
4 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
670
|
266K
|
4
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
PZ99
|
670 |
266K |
0 |
17/10/22 |
17/10/22 |
ASX - By Stock
|
670
|
266K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
PZ99
|
115 |
60K |
1 |
02/10/22 |
02/10/22 |
ASX - By Stock
|
115
|
60K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
PZ99
|
115 |
60K |
0 |
30/09/22 |
30/09/22 |
ASX - By Stock
|
115
|
60K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
PZ99
|
670 |
266K |
1 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
670
|
266K
|
1
|
|
ASX - By Stock
|
PAR |
Re:
General OA media and info
|
|
PZ99
|
670 |
266K |
7 |
27/09/22 |
27/09/22 |
ASX - By Stock
|
670
|
266K
|
7
|
|
ASX - By Stock
|
PAR |
Re:
Ann: Trading Halt
|
|
PZ99
|
276 |
109K |
3 |
11/08/22 |
11/08/22 |
ASX - By Stock
|
276
|
109K
|
3
|
|
ASX - By Stock
|
CSL |
Re:
News: CSL Australia's CSL says blood plasma fees are stabilising
|
|
PZ99
|
9 |
4.1K |
3 |
03/05/22 |
03/05/22 |
ASX - By Stock
|
9
|
4.1K
|
3
|
|
ASX - By Stock
|
PAR |
Re:
research reports and media
|
|
PZ99
|
4.4K |
2.0M |
4 |
29/04/22 |
29/04/22 |
ASX - By Stock
|
4.4K
|
2.0M
|
4
|
|
ASX - By Stock
|
PAR |
Re:
What do they want?
|
|
PZ99
|
32 |
14K |
0 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
32
|
14K
|
0
|
|
ASX - By Stock
|
PAR |
Re:
What do they want?
|
|
PZ99
|
32 |
14K |
0 |
16/03/22 |
16/03/22 |
ASX - By Stock
|
32
|
14K
|
0
|
|